WU Xian-bo, DONG Pei-zhi, ZHOU Hai, et al. Serum Pharmacochemistry of Mume Fructus by HPLC-MS and Principal Component Analysis[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(24): 118-122.
DOI:
WU Xian-bo, DONG Pei-zhi, ZHOU Hai, et al. Serum Pharmacochemistry of Mume Fructus by HPLC-MS and Principal Component Analysis[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(24): 118-122. DOI: 10.13422/j.cnki.syfjx.2014240118.
Serum Pharmacochemistry of Mume Fructus by HPLC-MS and Principal Component Analysis
Objective: To analyze components and metabolites in serum of rats after given of Mume Fructus by gavage. Method: Eight female rats were divided into Mume Fructus group and blank control group
former group were given Mume Fructus crude solution(0.633 6 g·mL-1 )2 mL·kg-1 by gavage
the latter with pure water. Four days later
solid phase extraction method was used to extract the drug-containing serum and blank serum
using Mume Fructus extracted by acetonitrile as medicinal materials control. Chromatography using Angient Zorbax Eclipse Plus C8(3.0 mm×100 mm
1.8 μm) for chromatographic column
using 0.1% formic acid solution-acetonitrile gradient elution
flow rate of 0.5 mL·min-1. Mass spectrometry using ESI source
within the scope of 50-1 200 m/z positive scanning mode. Mass spectrum data were preprocessed and principal component analyzed by Mzmine 2.9 software
using the results of principal component analysis and the database of prototype component to identify blood transitional component and metabolites. Result: In serum there were three components from the Mume Fructus original medicinal herbs(such as ursolic acid or oleanolic acid
medicagenic acid)
and there were 10 kinds of the metabolites. Conclusion: This method can be used for analysis of components of medicinal materials into the blood and its metabolites more objective and comprehensive
and it can be used to provide reference and basis for pharmacodynamics research of the Mume Fructus material.
In Vitro and in vivo Component Identification of DanshenyinBased on UPLC-Q-TOF-MS/MS
Comparative Analysis of Serum Pharmacochemistry of Alismatis Rhizoma Before and After Salt Processing Based on UPLC-Q-TOF-MS
Analysis on Material Basis of Anti-COPD Effect of Euphorbia helioscopia Based on Serum Pharmacochemistry and Network Pharmacology
Analysis of Pharmacodynamic Material Basis of Qingyan Formula Based on UPLC-Q-Orbitrap-MS and Molecular Docking
Meridian Tropism of Components in Bupleuri Radix Based on Nonalcoholic Steatohepatitis Model and Principal Component Analysis
Related Author
ZHANG Sitong
HU Xianrun
LIU Wenkang
LEI Jinchun
CHENG Xuemei
WU Xiaojun
CHEN Wansheng
LI Manlin
Related Institution
Key Laboratory for Standardization of Chinese Medicines,Ministry of Education, Shanghai Key Laboratory for Compound Chinese Medicines,Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine
Beijing City University
Tianjin University of Traditional Chinese Medicine
Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences